Q: I am looking at adding CPH to my portfolio. Would you suggest starting with a half position in todays market? Also I am wondering how to interpret the company's goals. For example, they are targeting $1biln cap by 2020. Based on the current number of shares (26million) that is a stock price of almost $40. Is this what management is suggesting here?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I purchased Cipher Pharmaceutical during jan.'15 at $17.60/share. It is now down to $11.11/share (37% loss). The fundamentals look pretty good (e.g. forward PE of 9.56). I would appreciate if you could fill me in about why you think it has tanked so badly and what is your outlook for it?
Q: I have a one half position in each of PHM and CRH. According to their last quarter IFRS results PHM had an EPS loss 0.012 and CRH had an EPS profit of 0.02. I am considering selling my PHM and buying a full position in CRH.
What do you think of this strategy?
Regards
What do you think of this strategy?
Regards
Q: Is PHM considered to be a US company to be reported under Form 1135?
Thanks
Joe
Thanks
Joe
Q: hello, a member asked if PHM was a USA corporation and was subject to "FORM 1135". you replied "yes". I contacted Dennis Wilson (corp development) at PHM & CXV, he told me PHM and CXV are both Canadian companies, WHO IS RIGHT/WRONG? and WHY? THANKS, fred
Q: Is there any reason for the slide in the stock??
Are yo still holding it?
Are yo still holding it?
Q: Hi 5i:
I'm seeking your advice on my health care /biotech holdings, and I'd like to know if I should shorten the list (I tend to hold too many stocks), make any substitutions, or change relative weightings. I hold five: IBB (full position); CRH (2/3 position), and CXR, GUD and PHM, all 1/3 positions, approximately. They together comprise 11% of the stock holdings in my actively managed portfolio. Also, do you think this is a reasonable total weight for the present market? Thanks for your valuable advice.
I'm seeking your advice on my health care /biotech holdings, and I'd like to know if I should shorten the list (I tend to hold too many stocks), make any substitutions, or change relative weightings. I hold five: IBB (full position); CRH (2/3 position), and CXR, GUD and PHM, all 1/3 positions, approximately. They together comprise 11% of the stock holdings in my actively managed portfolio. Also, do you think this is a reasonable total weight for the present market? Thanks for your valuable advice.
Q: Hello Team
Is there any red flags with the options the management keep issuing to themselves.
Thank You
Is there any red flags with the options the management keep issuing to themselves.
Thank You
Q: Hello Peter & Team,
I would be interested in your thoughts on the recent PHM acquisition?
Thank you for the great service.
Tim
I would be interested in your thoughts on the recent PHM acquisition?
Thank you for the great service.
Tim
Q: This stock has lost a quarter of its value since April 20. I realize there was a financing issue, but the steady downward momentum seems to be accelerating. I know growth stocks are volatile, but 25% is a serious fall with no end in sight. Last night on BNN Eric Nuttall described PHM is wildly overpriced and likely to take a huge fall if there is a market correction. Is it time to jump ship?
Q: Good Afternoon,
I just listened to the conference call from the end of April. Correct me if I'm wrong but I think I heard them say that a realistic longer term goal is now $1Bill in annual revenue? Not sure if I misheard them but they also said their EBITDA margin currently is around 60-65%? And companies like this could trade for 10-13x EBITDA? Thank-you
I just listened to the conference call from the end of April. Correct me if I'm wrong but I think I heard them say that a realistic longer term goal is now $1Bill in annual revenue? Not sure if I misheard them but they also said their EBITDA margin currently is around 60-65%? And companies like this could trade for 10-13x EBITDA? Thank-you
Q: Hi Peter & team, PHM halted....do you have any info?
Thank you.
Thank you.
Q: Hi Peter and team
With recent news from the company and no questions asked since Dec. 2013, what is your current view of it?
Gerry
With recent news from the company and no questions asked since Dec. 2013, what is your current view of it?
Gerry
Q: Which Health stock is better buy VRX or CXR. I would hold for 2 to 3 years
Q: POZEN Inc. announced today that they have purchased Tribute Pharmaceuticals and will create a new Company (Aralez Pharmaceuticals) that will trade on both the TSX and NASDAQ. Both stocks are up nicely today and Aralex appears to be well capitalized with additional capital being invested in Aralez.
I own some Tribute and have a few questions:
1. Do you have an opinion on the transaction?
2. Would you think investors in Tribute should sell now or wait and hold shares in the Aralez?
3. What would your thoughts be on buying more shares in Tribute or taking a position in POZEN Inc.
Don
I own some Tribute and have a few questions:
1. Do you have an opinion on the transaction?
2. Would you think investors in Tribute should sell now or wait and hold shares in the Aralez?
3. What would your thoughts be on buying more shares in Tribute or taking a position in POZEN Inc.
Don
Q: Can you please comment on the takeover Of TRX by Pozen and what would you recommend to do with TRX shares. Thanks
Q: I presently hold Concordia, PHM, Walgreen and CVS. In an attempt to increase the health care portion of my portfolio to roughly ten percent I am contemplating purchasing UNH ( United Healthcare) Appreciating you don't really cover US Stocks would I be better off simply adding to my CVS. Is there an overlap here between CVS and UNH and possibly WBA?
Thanks
Thanks
Q: Peter, there is some current speculation regarding US health care stocks and this US Supreme Court Ruling which will apparently happen this month which could throw a monkey wrench into the health care momentum. IE. King Versus Burwell. Could you comment on the potential impact this decision might have on health care stocks generally and patient home monitoring specifically.
Q: Please give your opinion on the GUD announcement today.
Q: I hold BNS and RY in my TFSA, both with large unrealized capital gains. I'm considering selling both and buying a Health Care ETF. If you consider this a good switch, what ETF would you recommend?